Skip to content

Clinical trials

Phase 1/2 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 1/2 Country / region: Israel Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20151
20161
20191
20212
20231
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Princess Maxima Center for Pediatric Oncology3
Amgen1
BioSight Ltd.1
Israeli Medical Association1
Mirror Biologics, Inc.1
Novartis Pharmaceuticals1
Sheba Medical Center1
Syndax Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma10
Leukemia5
Recurrence4
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma3
Leukemia, Myeloid, Acute2
Lymphoma, Non-Hodgkin2
Hematologic Neoplasms1
Hodgkin Disease1
Leukemia, Biphenotypic, Acute1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.